Kno2 Appoints Mark McAdoo to Board of Directors Amid Recent Growth
Summary
Prior to this role, he was co-founder and CEO of HEP-backed HealthQX – a data analytics firm in the value-based-care market segment. “Mark’s operational experience, proven track record and extensive network of healthcare leaders aligns well with our growth trajectory. His willingness to roll up his sleeves with the Kno2 leadership team will be a tremendous benefit to our partners, customers and employees.” “Interoperability has been a sought-after solution in the healthcare industry for more than a decade,” said McAdoo. Kno2 is the “real deal” and I am excited to help guide and help grow the organization.” Since raising a $15M Series A investment in July of last year, Kno2 has experienced significant growth in number of partners and customers participating over the Kno2 network. We are empowering healthcare to finally realize the true potential of interoperability by unleashing connectivity everywhere through a simple to use Communication API and robust tools for any business.